Gemcitabine in combination with capecitabine compared with gemcitabine combined with erlotinib in locally advanced or metastatic pancreatic cancer

被引：0
|
作者：
Khatri, P. [1 ]
Kumari, P. [2 ]
Beniwal, S. [3 ]
Samdariya, S. [4 ]
机构：
[1] Acharya Tulsi Canc Hosp & Res Ctr & Allied Hosp, Bikaner, India
[2] Acharya Tulsi Reg Canc Treatment & Res Ctr, Bikaner, India
[3] ATRCTRI, Bikaner, India
[4] AIIMS Jodhpur, Jodhpur, Rajasthan, India
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
RM-028
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [31] Budget impact model of adding erlotinib to a regimen of gemcitabine for the treatment of locally advanced, nonresectable or metastatic pancreatic cancer
    Danese, Mark D.
    Reyes, Carolina
    Northridge, Kelly
    Lubeck, Deborah
    Lin, Chin-Yu
    O'Connor, Paula
    CLINICAL THERAPEUTICS, 2008, 30 (04) : 775 - 784
  • [32] A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer
    In Gyu Hwang
    Joung-Soon Jang
    Sung Yong Oh
    Suee Lee
    Hyuk Chan Kwon
    Gyeong Won Lee
    Seil Go
    Myoung Hee Kang
    Young Joo Cha
    Jung Hun Kang
    Investigational New Drugs, 2012, 30 : 2371 - 2376
  • [33] A phase I/II study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma
    Jo, Jung Hyun
    Jung, Dawoon E.
    Lee, Hee Seung
    Park, Soo Been
    Chung, Moon Jae
    Park, Jeong Youp
    Bang, Seungmin
    Park, Seung Woo
    Cho, Sangsook
    Song, Si Young
    INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (09) : 1565 - 1577
  • [34] Radiation therapy in combination with cetuximab and gemcitabine in locally advanced pancreatic cancer
    Fiore, M.
    Trodella, L.
    Valeri, S.
    Floreno, B.
    Greco, C.
    Nappo, G.
    Molfese, E.
    Trecca, P.
    Coppola, R.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S72 - S73
  • [35] Dose Finding and Early Efficacy Study of Gemcitabine Plus Capecitabine in Combination With Bevacizumab Plus Erlotinib in Advanced Pancreatic Cancer
    Starling, Naureen
    Watkins, David
    Cunningham, David
    Thomas, Janet
    Webb, Janine
    Brown, Gina
    Thomas, Karen
    Oates, Jacqui
    Chau, Ian
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (33) : 5499 - 5505
  • [36] The biomarkers of gemcitabine and erlotinib treatment in advanced pancreatic cancer
    Irie, Kuniyasu
    Ueno, Makoto
    Kobayashi, Satoshi
    Gouda, Yoshihiro
    Ohkawa, Shinichi
    Manabu, Morimoto
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [37] Gemcitabine in locally advanced and/or metastatic bladder cancer
    von der Maase, H
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2000, 34 (03) : 175 - 184
  • [38] Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study
    Javle, M.
    Yu, J.
    Garrett, C.
    Pande, A.
    Kuvshinoff, B.
    Litwin, A.
    Phelan, J., III
    Gibbs, J.
    Iyer, R.
    BRITISH JOURNAL OF CANCER, 2009, 100 (12) : 1842 - 1845
  • [39] Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study
    M Javle
    J Yu
    C Garrett
    A Pande
    B Kuvshinoff
    A Litwin
    J Phelan
    J Gibbs
    R Iyer
    British Journal of Cancer, 2009, 100 : 1842 - 1845
  • [40] Efficiency of gemcitabine and capecitabine in the treatment of advanced pancreatic cancer
    Zeynalov, R.
    Musayev, I
    Giyasbeyli, S.
    Gasanzadeh, J.
    Dadashova, N.
    Ahadova, N.
    ANNALS OF ONCOLOGY, 2007, 18 : VII117 - VII117
12345